about
Application of MALDI-TOF mass spectrometry in clinical diagnostic microbiology.Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for caspofungin susceptibility testing of Candida and Aspergillus species.Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based method for discrimination between molecular types of Cryptococcus neoformans and Cryptococcus gattiiTyping of nosocomial outbreaks of Acinetobacter baumannii by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry.MALDI-TOF mass spectrometry in the clinical mycology laboratory: identification of fungi and beyond.Comparative evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry systems for identification of yeasts of medical importanceRapid antifungal susceptibility testing by matrix-assisted laser desorption ionization-time of flight mass spectrometry analysis.Development and validation of an in-house database for matrix-assisted laser desorption ionization-time of flight mass spectrometry-based yeast identification using a fast protein extraction procedure.Identification and typing of the Candida parapsilosis complex: MALDI-TOF MS vs. AFLP.Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) for identification and clustering of Neisseria gonorrhoeae.Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital.Targeted gene disruption in Candida parapsilosis demonstrates a role for CPAR2_404800 in adhesion to a biotic surface and in a murine model of ascending urinary tract infectionPotential Use of MALDI-ToF Mass Spectrometry for Rapid Detection of Antifungal Resistance in the Human Pathogen Candida glabrataMolecular Detection of Resistance to Azole Components.Molecular Detection of Resistance to Echinocandins.Clusters of patients with candidaemia due to genotypes of Candida albicans and Candida parapsilosis: differences in frequency between hospitals.Candida utilis catheter-related bloodstream infection.Comparative evaluation of BD Phoenix and vitek 2 systems for species identification of common and uncommon pathogenic yeasts.A rapid diagnostic workflow for cefotaxime-resistant Escherichia coli and Klebsiella pneumoniae detection from blood cultures by MALDI-TOF mass spectrometrySusceptibility Testing of Common and Uncommon Aspergillus Species against Posaconazole and Other Mold-Active Antifungal Azoles Using the Sensititre Method.A combined molecular typing approach does not discriminate Legionella pneumophila serogroup 1 strains of a predominant sequence-based type in Palermo, Italy.In vitro effect of clarithromycin and alginate lyase against helicobacter pylori biofilm.Microbiologic and clinical characteristics of biofilm-forming Candida parapsilosis isolates associated with fungaemia and their impact on mortality.Histoplasmosis in a lung transplant recipient from a nonendemic area
P50
Q27686939-9301944C-C740-45C0-B91E-67E9AA2B0A0DQ34007574-253FDBCB-2DC2-4C9D-96F4-00D13FB82631Q34246802-36065040-8510-4AA8-82A3-3650BB1B1F76Q34264267-B59F1945-FC25-481D-8B2A-81668C1D7D20Q34486439-7E4E36DE-88A5-496F-8DD3-18D8465FF6E8Q34662276-E496962C-125F-4D02-B8C1-FC3CEBCDE863Q34725107-79E8613F-7811-4916-BDE5-D27CFF6EDCF0Q34793588-A7C5277B-AB1F-4B37-9887-856B43564F23Q35098515-43A1C4D1-B672-4853-AAE9-DFB25DA5A09DQ35104155-F76CFCC0-94FB-4656-B8DB-D5C97182658EQ35708953-5C8EB01D-4AF4-4BC8-9C6E-607C85855D9FQ35746090-F9A7A1DD-2E54-4015-AEEE-DC63BE9081CAQ37197328-215AA1F7-0B01-49E4-A2B5-9ACF5250330BQ38613320-1EEB9C14-AE66-4916-A5FF-37392453F7A5Q40454797-8CE50DC0-4833-4BF9-8191-E2034F65F8CAQ40454803-87BF5983-D70E-462A-9D7A-AEFBB763E83EQ41325938-F4462722-5155-428C-93CE-40F897739027Q41618975-5E7A7349-C174-4842-B78C-BD237B805A35Q41868077-A45FF211-0B40-4787-A0F6-F80963B7654BQ42370798-3102C33B-D524-4C10-B01D-326716A665C3Q45199703-879337A3-EBC0-4C15-A00B-A868E18AF991Q45375935-E3772C6F-40DF-4FE3-BAA0-1FC503756FCBQ47712072-CA43D4CE-200D-4809-995F-A3BCC1C131AAQ50043791-CCEBC1E3-43D5-4A8E-AB1A-F92670EB9B30Q64128392-E95F6102-F340-466D-8995-76BD4A314FF1
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Antonietta Vella
@ast
Antonietta Vella
@en
Antonietta Vella
@es
Antonietta Vella
@nl
type
label
Antonietta Vella
@ast
Antonietta Vella
@en
Antonietta Vella
@es
Antonietta Vella
@nl
prefLabel
Antonietta Vella
@ast
Antonietta Vella
@en
Antonietta Vella
@es
Antonietta Vella
@nl
P106
P1153
48662812900
P31
P496
0000-0002-0495-8959